Molecules 2012, 17
5183
Chromatographic purification [n-hexane/EE 7:1 (v:v)]; Rf = 0.26) provided 0.4 g of 8a (1.7 mmol;
1
70%) as yellow solid. H-NMR (CDCl3, 400 MHz): δ 2.35 (s, 6H), 2.72 (s, 1H), 2.87 (s, 1H), 7.80
13
(d, J = 8.5 Hz, 4H), 7.50 (d, J = 8.5 Hz, 4H); C-NMR (CDCl3, 100 MHz): δ 21.0, 74.2, 75.3, 86.7,
126.0, 129.2, 137.8, 142.0; IR (ATR): 3539, 3450, 3286, 2923, 1717, 1510, 821 cm−1; EI-MS (60 °C):
m/z (%) 236 (100) [M+], 221 (84), 145 (57), 91 (57), 53 (60); HR-MS: (M+ = C17H16O) found:
236.1208, calc.: 236.1201.
1,1-bis-(4-Nitrophenyl)prop-2-yn-1-ol (8b): Compound 10b (0.8 g, 2.9 mmol) and ethynylmagnesium
bromide (5.9 mL, solution in THF 0.5 M, 2.9 mmol) were reacted following the general procedure.
Chromatographic purification [n-hexane/EE 3:1 (v:v)]; Rf = 0.29) provided 0.7 g of 8b (2.3 mmol;
78%) as yellow solid. 1H-NMR (CD2Cl2, 400 MHz): δ 3.05 (s, 1H), 3.07 (s, 1H), 7.80 (d, J = 9.2 Hz,
13
4H), 8.21 (d, J = 8.8 Hz, 4H); C-NMR (CD2Cl2, 100 MHz): δ 73.3, 77.9, 83.9, 123.9, 126.9, 147.7,
149.8; IR (ATR): 3486, 3288, 2927, 2588, 2117, 1700, 1608, 1519, 1345, 702 cm−1; EI-MS (200 °C):
m/z (%) 298 (14) [M]+, 281 (43), 251 (52), 176 (100); HR-MS (m/e) found for (M+) 298.0588, calc.
for C15H10N2O5 298.0590.
3.3. General Procedure for the Synthesis of the Precatalysts 5a–c
A dry and nitrogen-flushed Schlenk-tube was successively charged with RuCl2 (PPh3)3
(1.00 equiv.), X (1.15 equiv.), PCy3 (2.30 equiv.) and dry THF (c = 0.025 M). The solution was heated
to 70 °C for 16 h, whereupon the solvent was removed to afford the crude mixture. Dissolved in a
minimum amount of DCM the residue was treated with an excess of n-hexane to obtain a precipitate,
which was filtered and washed with cold n-hexane to yield the desired precatalyst.
(PCy3)2Cl2Ru[bis-(4-methylphenyl)-allenylidene] (5a): The reaction of RuCl2(PPh3)3 (100 mg,
0.10 mmol), 8a (28.3 mg, 0.12 mmol), PCy3 (67.3 mg, 0.24 mmol) afforded 5a (94.9 mg, 0.10 mmol,
1
96%) as an orange brown powder after precipitation, following the general procedure. H-NMR
(CD2Cl2, 500 MHz): δ 1.13–1.26 (m, 24H), 1.42–1.49 (m, 12H), 1.65–1.67 (m, 12H), 1.98 (d, J = 12.2 Hz,
13
12H), 2.18 (s, 6H), 2.60–2.65 (m, 6H), 7.10 (d, J = 8.0 Hz, 4H), 7.70 (d, J = 8.2 Hz, 4H); C-NMR
(CD2Cl2, 125 MHz): δ 21.5, 26.6, 28.0, 29.7, 32.1, 129.5, 129.8, 139.0, 143.9, 144.3, 186.3, 214.2;
31P-NMR (CD2Cl2, 125 MHz): δ 40.6; IR (ATR): cm−1 3411, 2924, 2849, 1913, 1715, 1436; FAB-MS:
m/z (%) 951 (40) [M]+, 878 (100) [M−2Cl]+.
(PCy3)2Cl2Ru[bis-(4-nitrophenyl)-allenylidene] (5b): The reaction of RuCl2(PPh3)3 (100 mg, 0.10 mmol),
8b (35.8 mg, 0.12 mmol), PCy3 (67.3 mg, 0.24 mmol) afforded 5b (57.3 mg, 0.06 mmol, 57%) as a
dark brown powder after precipitation, following the general procedure. 1H-NMR (CD2Cl2, 500 MHz):
δ 1.12–1.25 (m, 24H), 1.41–1.48 (m, 12H), 1.66 (d, J = 10.7 Hz, 12H), 1.92 (d, J = 11.9 Hz, 12H),
2.55–2.65 (m, 6H), 7.95 (d, J = 8.7 Hz, 4H), 8.18 (d, J = 9.1 Hz, 4H); 13C-NMR (CD2Cl2, 125 MHz): δ
26.4, 27.1, 29.5, 32.4, 114.9, 131.7, 140.5, 146.2, 160.4, 190.1, 216.8; 31P-NMR (CD2Cl2, 125 MHz): δ
44.4; IR (ATR): cm−1 3348, 3076, 2929, 2854, 1926, 1525, 1347, 696; FAB-MS: m/z (%) 940 (39)
[M−2Cl]+, 843 (100), 819 (60).